Annexin A1 attenuates EMT and metastatic potential in breast cancer.
about
The function of SARI in modulating epithelial-mesenchymal transition and lung adenocarcinoma metastasisUpregulation of Hsp90-beta and annexin A1 correlates with poor survival and lymphatic metastasis in lung cancer patientsMining genome sequencing data to identify the genomic features linked to breast cancer histopathology.The CO-Regulation Database (CORD): a tool to identify coordinately expressed genesIdentification and dynamic changes of RNAs isolated from RALY-containing ribonucleoprotein complexes.17β-estradiol regulates giant vesicle formation via estrogen receptor-alpha in human breast cancer cells.Lack of association of two common polymorphisms rs2910164 and rs11614913 with susceptibility to hepatocellular carcinoma: a meta-analysis.Correlation of ANXA1 expression with drug resistance and relapse in bladder cancerMembrane lipidome of an epithelial cell line.Annexin A6 contributes to the invasiveness of breast carcinoma cells by influencing the organization and localization of functional focal adhesions.Characterization of a pituitary-tumor-derived cell line, TtT/GF, that expresses Hoechst efflux ABC transporter subfamily G2 and stem cell antigen 1.Interleukin-like epithelial-to-mesenchymal transition inducer activity is controlled by proteolytic processing and plasminogen-urokinase plasminogen activator receptor system-regulated secretion during breast cancer progressionProtein-coding and microRNA biomarkers of recurrence of prostate cancer following radical prostatectomyAberrantly expressed Fra-1 by IL-6/STAT3 transactivation promotes colorectal cancer aggressiveness through epithelial-mesenchymal transition.Effects of Two Common Polymorphisms rs2910164 in miR-146a and rs11614913 in miR-196a2 on Gastric Cancer Susceptibility.Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosis.High-throughput mRNA and miRNA profiling of epithelial-mesenchymal transition in MDCK cellsIdentification of Breast Cancer Prognosis Markers via Integrative AnalysisMajority of differentially expressed genes are down-regulated during malignant transformation in a four-stage modelPotential role of Anxa1 in cancer.Epithelial-mesenchymal transition in pancreatic carcinomaAnnexin A1 in primary tumors promotes melanoma dissemination.Focal Adhesion Kinase (FAK) tyrosine 397E mutation restores the vascular leakage defect in endothelium-specific FAK-kinase dead mice.Cysteine-rich secretory protein 3 plays a role in prostate cancer cell invasion and affects expression of PSA and ANXA1.SSX2 regulates focal adhesion but does not drive the epithelial to mesenchymal transition in prostate cancer.MicroRNA-196a promotes an oncogenic effect in head and neck cancer cells by suppressing annexin A1 and enhancing radioresistance.Silencing of hHS6ST2 inhibits progression of pancreatic cancer through inhibition of Notch signalling.Four common polymorphisms in microRNAs and the risk of adult glioma in a Chinese case-control study.ANXA1 affects cell proliferation, invasion and epithelial-mesenchymal transition of oral squamous cell carcinoma.Co-overexpression of Hsp90-β and annexin A1 with a significantly positive correlation contributes to the diagnosis of lung cancer.
P2860
Q21134555-31D3D175-D637-4E0A-A5CC-EBF6FE833614Q21198841-5514025C-226A-4A3B-8863-6EE0BFA02C6DQ30786619-1A62B48B-61F4-489B-864D-0E620A8886B1Q31152739-8CB57E41-6FF7-4EB5-AC35-7745FEEF95E9Q33879051-586EEB98-B992-486D-B45E-7A40A8948790Q33917559-B986F05B-8E75-46CF-A1E1-A8239376C480Q34328585-C8E6B64E-79A1-4FFA-9464-70D927F01D16Q34371175-BBE8FFE4-79C6-4E09-839C-73289D6DE192Q34549906-F158E458-30F6-47CF-8965-11AB90A66846Q34629018-CA78B2CF-DAC4-4846-BAEB-82DAA5BB6A82Q34861698-96E91F3A-B2AD-4EDE-BCF0-45901E159C7FQ34999819-022C2460-D93C-4CC7-9C86-9526596313EEQ35070161-CFF122F3-BAA3-447F-A15D-037A6AE1E179Q35356072-850B028D-4C87-4270-967B-CF4F0426D620Q35578761-9256A300-A790-4431-B76B-1E09E3A8BA2AQ35681656-442987C9-129C-4F1C-BF79-5237E8AA302BQ35842588-BA9D5337-3C7C-413B-A1CA-B3853A4E726CQ36076435-B90003C5-3AE6-4F13-8507-BC0383DE18B9Q36798968-396D5D15-4676-4574-81AE-1FC2064A42FEQ38155207-855190CE-295D-4192-83FB-5077B93298E9Q38166588-BB32FD69-B4CA-467B-8A10-9F05D3AB9E09Q38305975-DFE633CC-FD0B-4AFD-BF67-B2A2F2F47C7EQ38706013-2A124DB9-6435-46D3-8ACA-6FA780BBF444Q38835384-02F96C96-F78F-4C34-A3D5-1C3257D3E17EQ38856316-98993550-6680-454B-9C79-DD057104A6A1Q38927176-97EA971D-3463-43AE-8153-6B936A71F93DQ39569424-FDE0AC00-CA5D-41CE-A4D6-2220A3CB5F61Q44675482-00A7AB04-928B-47E1-840A-20DF9A210F03Q47141042-D6E3CEEB-2459-4456-B79C-302E427C788CQ51691884-FD6257D3-3088-4553-A7C2-AF63AEE50ACD
P2860
Annexin A1 attenuates EMT and metastatic potential in breast cancer.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Annexin A1 attenuates EMT and metastatic potential in breast cancer.
@ast
Annexin A1 attenuates EMT and metastatic potential in breast cancer.
@en
type
label
Annexin A1 attenuates EMT and metastatic potential in breast cancer.
@ast
Annexin A1 attenuates EMT and metastatic potential in breast cancer.
@en
prefLabel
Annexin A1 attenuates EMT and metastatic potential in breast cancer.
@ast
Annexin A1 attenuates EMT and metastatic potential in breast cancer.
@en
P2093
P2860
P356
P1476
Annexin A1 attenuates EMT and metastatic potential in breast cancer.
@en
P2093
Christoph A Gebeshuber
Eva-Maria Wiedemann
Hartmut Beug
Ivana Custic
Memetcan Alacakaptan
Sabine Maschler
P2860
P304
P356
10.1002/EMMM.201000095
P577
2010-10-01T00:00:00Z